A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00241371 · TERMINATED

Trial details

NCT number: NCT00241371
Sponsor: Washington University School of Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2005-03-01
Primary completion: 2005-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.